MetaCap

Agilent Technologies (A) vs Revvity (RVTY)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

Revvity (RVTY) has outperformed Agilent Technologies (A) over the past year, gaining 47.8% versus a gain of 12.6%. Over five years, A leads with a +12.0% price change compared with -20.7% for RVTY. Agilent Technologies is the larger company by market cap ($48.04 billion vs $16.21 billion), about 3.0 times the size.

On valuation, Revvity trades at a lower forward P/E (24.4x vs 25.4x for Agilent Technologies). Agilent Technologies offers the higher dividend yield (0.59% vs 0.19%). Agilent Technologies converts more of its revenue into profit, with a net margin of 18.8% versus 8.4%.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

A+12.65%RVTY+47.78%
+73%+21%-32%
Nov 21, 20251 yearNov 20, 2026
A+3.70%RVTY-23.09%
+10%-25%-59%
Nov 15, 20215 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

A versus RVTY key metrics
MetricARVTY
Share price$170.38$145.22
Market cap$48.04B$16.21B
1-day change-2.83%-4.20%
YTD return+25.21%+50.10%
1-year return+12.65%+47.78%
5-year return+12.04%-20.68%
P/E ratio (TTM)33.6164.54
Forward P/E25.3624.38
EPS (TTM)$5.07$2.25
Dividend yield0.59%0.19%
Annual dividend$1.01$0.28
Revenue (latest FY)$6.95B$2.86B
Revenue growth (YoY)+6.73%+3.67%
Net income (latest FY)$1.30B$241.20M
Gross margin52.43%—
Operating margin21.29%12.49%
Net margin18.75%8.45%
52-week high$182.99$171.74
52-week low$108.35$81.22
Distance from 52-week high-6.89%-15.44%
Analyst consensusbuybuy
Avg. price target upside+7.49%+18.03%
Average volume2.32M1.91M
Shares outstanding281.97M111.64M
Employees18,20011,000
SectorIndustrialsIndustrials
IndustryBiotechnology: Laboratory Analytical InstrumentsBiotechnology: Laboratory Analytical Instruments

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • Agilent Technologies is about 3.0 times larger than Revvity by market value ($48.04B vs $16.21B).
  • RVTY has outperformed A by 35.1 percentage points over the past year.
  • Revvity trades at a higher earnings multiple (64.5x vs 33.6x trailing P/E).
  • Agilent Technologies is more profitable, keeping 18.8 cents of every revenue dollar as net income versus 8.4 cents for Revvity.

About Agilent Technologies

A stock →

Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide.

Industrials · Biotechnology: Laboratory Analytical Instruments · 18,200 employees

About Revvity

RVTY stock →

Revvity, Inc. provides health sciences solutions, technologies, and services.

Industrials · Biotechnology: Laboratory Analytical Instruments · 11,000 employees

A vs RVTY FAQ

Which is bigger, Agilent Technologies or Revvity?

Agilent Technologies (A) is larger, with a market capitalization of $48.04B compared with $16.21B for Revvity (RVTY).

Which stock has performed better over the past year, A or RVTY?

RVTY returned +47.78% over the past 12 months, compared with +12.65% for A (price return, excluding dividends). Past performance does not predict future results.

Which has the lower P/E ratio, A or RVTY?

A has the lower trailing P/E at 33.6, versus 64.5 for RVTY. A lower P/E is not by itself a sign of a better investment; it can reflect slower expected growth or higher risk.

Which pays a higher dividend, Agilent Technologies or Revvity?

Agilent Technologies has the higher yield at 0.59%, compared with 0.19% for Revvity.

Are Agilent Technologies and Revvity in the same industry?

Yes. Both are classified in the Biotechnology: Laboratory Analytical Instruments industry within the Industrials sector.

More comparisons